Rowe CC - Search Results

1

Tackling Dementia Together via The Australian Dementia Network (ADNeT): A Summary of Initiatives, Progress and Plans.

Naismith SL, Michaelian JC, Santos C, Mehrani I, Robertson J, Wallis K, Lin X, Ward SA, Martins R, Masters CL, Breakspear M, Ahern S, Fripp J, Schofield PR, Sachdev PS, Rowe CC. Naismith SL, et al. Among authors: rowe cc. J Alzheimers Dis. 2023;96(3):913-925. doi: 10.3233/JAD-230854. J Alzheimers Dis. 2023. PMID: 37927266 Free PMC article. Review.

2

Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease.

Villemagne VL, Rowe CC, Macfarlane S, Novakovic KE, Masters CL. Villemagne VL, et al. Among authors: rowe cc. J Clin Neurosci. 2005 Apr;12(3):221-30. doi: 10.1016/j.jocn.2004.03.011. J Clin Neurosci. 2005. PMID: 15851069 Review.

3

Rare genetically defined causes of dementia.

Novakovic KE, Villemagne VL, Rowe CC, Masters CL. Novakovic KE, et al. Among authors: rowe cc. Int Psychogeriatr. 2005;17 Suppl 1:S149-94. doi: 10.1017/s1041610205002012. Int Psychogeriatr. 2005. PMID: 16240489 Review.

4

Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease.

Opazo C, Luza S, Villemagne VL, Volitakis I, Rowe C, Barnham KJ, Strozyk D, Masters CL, Cherny RA, Bush AI. Opazo C, et al. Aging Cell. 2006 Feb;5(1):69-79. doi: 10.1111/j.1474-9726.2006.00196.x. Aging Cell. 2006. PMID: 16441845 Free article.

5

Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.

Ng S, Villemagne VL, Berlangieri S, Lee ST, Cherk M, Gong SJ, Ackermann U, Saunder T, Tochon-Danguy H, Jones G, Smith C, O'Keefe G, Masters CL, Rowe CC. Ng S, et al. Among authors: rowe cc. J Nucl Med. 2007 Apr;48(4):547-52. doi: 10.2967/jnumed.106.037762. J Nucl Med. 2007. PMID: 17401090 Free article.

6

Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.

Ng SY, Villemagne VL, Masters CL, Rowe CC. Ng SY, et al. Among authors: rowe cc. Arch Neurol. 2007 Aug;64(8):1140-4. doi: 10.1001/archneur.64.8.1140. Arch Neurol. 2007. PMID: 17698704

7

In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.

Fodero-Tavoletti MT, Smith DP, McLean CA, Adlard PA, Barnham KJ, Foster LE, Leone L, Perez K, Cortés M, Culvenor JG, Li QX, Laughton KM, Rowe CC, Masters CL, Cappai R, Villemagne VL. Fodero-Tavoletti MT, et al. Among authors: rowe cc. J Neurosci. 2007 Sep 26;27(39):10365-71. doi: 10.1523/JNEUROSCI.0630-07.2007. J Neurosci. 2007. PMID: 17898208 Free PMC article.

8

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC. Pike KE, et al. Among authors: rowe cc. Brain. 2007 Nov;130(Pt 11):2837-44. doi: 10.1093/brain/awm238. Epub 2007 Oct 10. Brain. 2007. PMID: 17928318

9

Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population.

Rimajova M, Lenzo NP, Wu JS, Bates KA, Campbell A, Dhaliwal SS, McCarthy M, Rodrigues M, Paton A, Rowe C, Foster JK, Martins RN. Rimajova M, et al. J Alzheimers Dis. 2008 Mar;13(2):137-46. doi: 10.3233/jad-2008-13203. J Alzheimers Dis. 2008. PMID: 18376055

10

The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias.

Villemagne VL, Fodero-Tavoletti MT, Pike KE, Cappai R, Masters CL, Rowe CC. Villemagne VL, et al. Among authors: rowe cc. Mol Neurobiol. 2008 Aug;38(1):1-15. doi: 10.1007/s12035-008-8019-y. Epub 2008 Aug 9. Mol Neurobiol. 2008. PMID: 18690556 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

400 results

Search Page